(1)
Papp, K.; Reich, K.; Blauvelt, A.; Thaci, D.; Sinclair, R.; Tyring, S. K.; Cichanowitz, N.; Green, S.; Li, Q.; La Rosa, C. Clinical Efficacy or Tildrakizumab in Patients With Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies. J of Skin 2018, 2, S4.